Cellectar Biosciences, Inc.
Cellectar Biosciences is a late-stage clinical biopharmaceutical company focused on discovering and developing proprietary drugs for the treatment of cancer.
/10
Transparency ranking
Work at Cellectar Biosciences, Inc.?
Tell us what we're missing about working at Cellectar Biosciences, Inc. so we can make the job search more transparent for everyone.
Tell us what it's like to work at Cellectar Biosciences, Inc.!Description
Cellectar Biosciences, Inc. is a late-stage clinical biopharmaceutical company dedicated to developing proprietary drugs for cancer treatment. Their focus lies in leveraging their Phospholipid Drug Conjugate™ (PDC) delivery platform to create next-generation, cancer cell-targeting therapies that offer improved efficacy and enhanced safety through reduced off-target effects. The company's lead asset, iopofosine I 131, is a small-molecule PDC designed to deliver iodine-131 (radioisotope) directly to cancer cells, while minimizing exposure to healthy tissues.
Cellectar actively pursues independent development of their PDC therapies as well as collaborations with other research and development partners. Their diverse product pipeline includes proprietary preclinical PDC chemotherapeutic programs and multiple partnered PDC assets. Their ongoing clinical studies for iopofosine I 131 are focused on a range of cancers, including Waldenstrom's macroglobulinemia, multiple myeloma, and pediatric cancers, demonstrating a commitment to addressing a spectrum of unmet needs in oncology.
Mission
Cellectar Biosciences is a late-stage clinical biopharmaceutical company dedicated to discovering and developing proprietary drugs for the treatment of cancer. Their core objective is to leverage their proprietary Phospholipid Drug Conjugate™ (PDC) delivery platform to develop the next-generation of cancer cell-targeting treatments, delivering improved efficacy and better safety with fewer off-target effects.
Culture
Cellectar Biosciences promotes a culture of innovation, collaboration, and determination. They emphasize a strong sense of purpose and dedication to making a positive impact on the lives of cancer patients, families, and caregivers. This culture is driven by leadership and permeates throughout the entire company, fostering a supportive environment where employees feel empowered to contribute their best work.
DE&I
Cellectar Biosciences, Inc. does not have a public statement or mention of their approach to diversity, equity and inclusion on their website.
Similar companies. But verified.
